durapatite has been researched along with Stomach Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, X; Liang, T; Liu, C; Qian, J; Yuan, Y | 1 |
Huang, B; Huang, S; Li, Y; Liu, F; Long, Z; Xue, Z; Zhou, K; Zhu, S | 1 |
Chen, X; Deng, C; Tang, S; Zhang, M | 1 |
3 other study(ies) available for durapatite and Stomach Neoplasms
Article | Year |
---|---|
Correlation of particle properties with cytotoxicity and cellular uptake of hydroxyapatite nanoparticles in human gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cytoplasm; Cytotoxins; Durapatite; Humans; Nanoparticles; Stomach Neoplasms | 2016 |
[Hydroxyapatite nanoparticles: a novel material of gene carrier].
Topics: Animals; Biocompatible Materials; Calcium Phosphates; Drug Carriers; Durapatite; Genetic Therapy; Mice; Nanostructures; Stomach Neoplasms; Transfection; Tumor Cells, Cultured | 2005 |
Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Durapatite; Enzyme Activation; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Time Factors | 2007 |